• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖-表观遗传学-微生物群轴:治疗干预策略

The Obesity-Epigenetics-Microbiome Axis: Strategies for Therapeutic Intervention.

作者信息

Nohesara Shabnam, Mostafavi Abdolmaleky Hamid, Pirani Ahmad, Pettinato Giuseppe, Thiagalingam Sam

机构信息

Department of Medicine (Biomedical Genetics), Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.

Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boson, MA 02215, USA.

出版信息

Nutrients. 2025 May 1;17(9):1564. doi: 10.3390/nu17091564.

DOI:10.3390/nu17091564
PMID:40362873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12073275/
Abstract

Obesity (OB) has become a serious health issue owing to its ever-increasing prevalence over the past few decades due to its contribution to severe metabolic and inflammatory disorders such as cardiovascular disease, type 2 diabetes, and cancer. The unbalanced energy metabolism in OB is associated with substantial epigenetic changes mediated by the gut microbiome (GM) structure and composition alterations. Remarkably, experimental evidence also indicates that OB-induced epigenetic modifications in adipocytes can lead to cellular "memory" alterations, predisposing individuals to weight regain after caloric restriction and subsequently inducing inflammatory pathways in the liver. Various environmental factors, especially diet, play key roles in the progression or prevention of OB and OB-related disorders by modulating the GM structure and composition and affecting epigenetic mechanisms. Here, we will first focus on the key role of epigenetic aberrations in the development of OB. Then, we discuss the association between abnormal alterations in the composition of the microbiome and OB and the interplays between the microbiome and the epigenome in the development of OB. Finally, we review promising strategies, including prebiotics, probiotics, a methyl-rich diet, polyphenols, and herbal foods for the prevention and/or treatment of OB via modulating the GM and their metabolites influencing the epigenome.

摘要

肥胖(OB)已成为一个严重的健康问题,在过去几十年里其患病率不断上升,因为它会导致严重的代谢和炎症性疾病,如心血管疾病、2型糖尿病和癌症。肥胖中的能量代谢失衡与肠道微生物群(GM)结构和组成改变介导的大量表观遗传变化有关。值得注意的是,实验证据还表明,肥胖诱导的脂肪细胞表观遗传修饰可导致细胞“记忆”改变,使个体在热量限制后易重新增重,并随后在肝脏中诱导炎症途径。各种环境因素,尤其是饮食,通过调节肠道微生物群的结构和组成以及影响表观遗传机制,在肥胖及肥胖相关疾病的进展或预防中起关键作用。在这里,我们首先将关注表观遗传异常在肥胖发生发展中的关键作用。然后,我们将讨论微生物群组成的异常改变与肥胖之间的关联,以及在肥胖发生发展过程中微生物群与表观基因组之间的相互作用。最后,我们回顾了一些有前景的策略,包括益生元、益生菌、富含甲基的饮食、多酚和草药食品,它们通过调节肠道微生物群及其影响表观基因组的代谢产物来预防和/或治疗肥胖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/12073275/77e0144a64f6/nutrients-17-01564-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/12073275/c7e6fdd26a7a/nutrients-17-01564-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/12073275/db628ebfe96d/nutrients-17-01564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/12073275/77e0144a64f6/nutrients-17-01564-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/12073275/c7e6fdd26a7a/nutrients-17-01564-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/12073275/db628ebfe96d/nutrients-17-01564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1313/12073275/77e0144a64f6/nutrients-17-01564-g003.jpg

相似文献

1
The Obesity-Epigenetics-Microbiome Axis: Strategies for Therapeutic Intervention.肥胖-表观遗传学-微生物群轴:治疗干预策略
Nutrients. 2025 May 1;17(9):1564. doi: 10.3390/nu17091564.
2
The Gut Microbial Regulation of Epigenetic Modification from a Metabolic Perspective.从代谢角度看肠道微生物对表观遗传修饰的调控。
Int J Mol Sci. 2024 Jun 29;25(13):7175. doi: 10.3390/ijms25137175.
3
Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.微生物失调诱导的肥胖:肠道微生物群在能量代谢稳态中的作用。
Br J Nutr. 2020 May 28;123(10):1127-1137. doi: 10.1017/S0007114520000380. Epub 2020 Feb 3.
4
Understanding the role of the human gut microbiome in overweight and obesity.了解人类肠道微生物组在超重和肥胖中的作用。
Ann N Y Acad Sci. 2024 Oct;1540(1):61-88. doi: 10.1111/nyas.15215. Epub 2024 Sep 16.
5
Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.饮食、肠道微生物群与肥胖:与宿主遗传学和表观遗传学的关联及其潜在应用。
Adv Nutr. 2019 Jan 1;10(suppl_1):S17-S30. doi: 10.1093/advances/nmy078.
6
Epigenetic Aberrations in Major Psychiatric Diseases Related to Diet and Gut Microbiome Alterations.主要精神疾病相关的表观遗传学异常与饮食和肠道微生物组改变有关。
Genes (Basel). 2023 Jul 24;14(7):1506. doi: 10.3390/genes14071506.
7
The role of the gut microbiota in the onset and progression of heart failure: insights into epigenetic mechanisms and aging.肠道微生物群在心力衰竭的发生和进展中的作用:对表观遗传机制和衰老的认识。
Clin Epigenetics. 2024 Nov 29;16(1):175. doi: 10.1186/s13148-024-01786-9.
8
Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency.膳食多酚对肠道微生物群的有益影响及改善递送效率的策略。
Nutrients. 2019 Sep 13;11(9):2216. doi: 10.3390/nu11092216.
9
Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies.微生物群诱导的抑郁障碍中的表观遗传改变是营养和益生菌治疗的靶点。
Genes (Basel). 2023 Dec 14;14(12):2217. doi: 10.3390/genes14122217.
10
An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression.肥胖相关的肠道微生物组会重新编程肠道表观基因组,导致结肠基因表达的改变。
Genome Biol. 2018 Jan 23;19(1):7. doi: 10.1186/s13059-018-1389-1.

引用本文的文献

1
Epigenetics and Gut Microbiota in the Pathogenesis and Treatment of Bipolar Disorder (BD).表观遗传学与肠道微生物群在双相情感障碍(BD)发病机制及治疗中的作用
Cells. 2025 Jul 18;14(14):1104. doi: 10.3390/cells14141104.

本文引用的文献

1
, a propionate-producing bacterium, contributes to GPR41 signaling and metabolic regulation in high-fat diet-induced obesity in mice.一种产丙酸的细菌,在高脂饮食诱导的小鼠肥胖中有助于GPR41信号传导和代谢调节。
Front Nutr. 2025 Apr 3;12:1542196. doi: 10.3389/fnut.2025.1542196. eCollection 2025.
2
Grape pomace extract attenuates high fat diet-induced endotoxemia and liver steatosis in mice.葡萄渣提取物可减轻高脂饮食诱导的小鼠内毒素血症和肝脂肪变性。
Food Funct. 2025 Mar 17;16(6):2515-2529. doi: 10.1039/d4fo06332e.
3
Efficacy of microbiome-targeted interventions in obesity management- A comprehensive systematic review.
微生物群靶向干预在肥胖管理中的疗效——一项全面的系统评价。
Diabetes Metab Syndr. 2025 Feb;19(2):103208. doi: 10.1016/j.dsx.2025.103208. Epub 2025 Feb 18.
4
Effects of oral supplementation of probiotics on body weight and visceral fat in obese patients: a meta-analysis and systematic review.口服补充益生菌对肥胖患者体重和内脏脂肪的影响:一项荟萃分析和系统评价
Sci Rep. 2025 Feb 21;15(1):6355. doi: 10.1038/s41598-025-90820-8.
5
Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10.脂肪组织来源的微小RNA-450a-5p通过下调双特异性磷酸酶10诱导2型糖尿病。
Mol Biomed. 2025 Feb 6;6(1):7. doi: 10.1186/s43556-025-00247-w.
6
Exploring serum miR-33b as a novel diagnostic marker for hypercholesterolemia and obesity: insights from a pilot case-control study.探索血清miR-33b作为高胆固醇血症和肥胖症的新型诊断标志物:一项初步病例对照研究的见解
BMC Endocr Disord. 2025 Jan 30;25(1):27. doi: 10.1186/s12902-025-01849-9.
7
Depot-specific acetylation profiles of adipose tissues-therapeutic targets for metabolically unhealthy obesity.脂肪组织特定储存部位的乙酰化谱——代谢不健康型肥胖的治疗靶点
Diabetol Metab Syndr. 2025 Jan 29;17(1):36. doi: 10.1186/s13098-025-01599-7.
8
Mitochondrial fatty acid oxidation regulates monocytic type I interferon signaling via histone acetylation.线粒体脂肪酸氧化通过组蛋白乙酰化调节单核细胞I型干扰素信号传导。
Sci Adv. 2025 Jan 24;11(4):eadq9301. doi: 10.1126/sciadv.adq9301. Epub 2025 Jan 22.
9
Maternal obesity alters histone modifications mediated by the interaction between EZH2 and AMPK, impairing neural differentiation in the developing embryonic brain cortex.母体肥胖会改变由EZH2和AMPK相互作用介导的组蛋白修饰,损害发育中的胚胎脑皮质中的神经分化。
J Biol Chem. 2025 Feb;301(2):108173. doi: 10.1016/j.jbc.2025.108173. Epub 2025 Jan 10.
10
Association between gut microbiota and short-chain fatty acids in children with obesity.肥胖儿童肠道微生物群与短链脂肪酸之间的关联
Sci Rep. 2025 Jan 2;15(1):483. doi: 10.1038/s41598-024-84207-4.